Zum Inhalt

Lignans from Sambucus williamsii Protect Bone Via Microbiome

  • Open Access
  • 05.09.2024
  • REVIEW
Erschienen in:

Abstract

Purpose of Review

Traditional Chinese Medicine has a unique system to diagnose and treat bone diseases with symptoms similar to those of osteoporosis. Sambucus williamsii Hance (SWH), a folk medicine in northern part of China for fractures healing and pain alleviation, has been demonstrated to exert bone anabolic effects in ovariectomized (OVX) rat and mice models in our previous studies. Lignans were identified to be the main bioactive fractions of SWH. However, pharmacokinetics study showed that the levels of lignan were too low to be detected in rat serum even upon taking 15 times of the effective dose of lignan-rich fraction from SWH. We hypothesize that lignans from SWH might exert its bone protective effect via the gut microbiome.

Recent Findings

Our study revealed that the lignan-rich fraction of SWH did not influence the diversity of gut microbiota in OVX rats, but significantly increased the abundance of a few phyla, in particular, the restoration of the abundance of several genera that was directly correlated with bone mineral density (BMD). In addition, a subsequent metabolomic study indicated that serotonin, a neurotransmitter synthesized in the intestine and influenced by gut microbiota, may be involved in mediating the bone protective action of the lignans. Gut-derived serotonin is thought to inhibit bone growth. Based on this finding, several inhibitors that suppressed the synthesis of serotonin were identified from the lignans of SWH.

Summary

Our studies suggested that microbiome is an indispensable factor for lignans derived from S. willimasii to exert bone beneficial effects.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Lignans and its Role on Bone Health

The proportion of the world's population over 60 years will be nearly double from 12 to 22% between 2015 to 2050 [1]. It is anticipated that 21.2% of women and 6.3% of men globally will suffer from osteoporosis and might lead to almost 70 fragility fracture per minute [2]. Hormonal changes, especially estrogen deficiency associated with menopause, and aging are the major contributing factors to the pathogenesis of osteoporosis.
Phytoestrogens, which are classically defined as phytochemicals that possess similar chemical structures to endogenous estrogen, are considered to be potential alternatives to hormone replacement therapy for management of estrogen deficiency-induced symptoms in menopausal women [3]. Lignans, one of the three major classes of phytoestrogens, are widely present in a variety of plant foods, including seeds, beans, whole grains, bran, fruits, vegetables and beverages such as tea and coffee [4]. Although the epidemiological studies are inconclusive, numerous health benefits have been attributed to the intake of naturally lignan-rich foods, including the reduction of risk of heart disease, menopausal symptoms, breast cancer and osteoporosis [3, 5].
Flaxseed and sesame seeds, derived from Linum usitatissimum L. and Sesamum indicium, respectively, are the two richest known sources of lignans. The consumption of flaxseed in various forms including total extract, power, flour, and oil, exhibited positive effects on bone mineral density (BMD) and bone metabolism in different animal models and in several clinical studies [6]. From 2013 to 2022, six studies reported that sesame seeds intake only, or in combination with peanut seeds or black seeds, were beneficial for improving BMD and serum bone biochemical markers in postmenopausal animal models [7]. In contrast, a randomized, double-blind clinical trial including 199 healthy menopausal women consuming 40 flaxseed/d (n = 101) or wheat germ placebo (n = 98) for 12 months, revealed that flaxseed incorporation into the diet of healthy menopausal women did not alter the BMD in lumbar or femoral neck as compared with wheat germ placebo [8]. Due to the limited available clinical studies, the effects of lignans on bone health are inconclusive.

Lignan Bioavailability and Correlation with Gut Microbiota

Several early studies revealed that ingested lignans were deglycosylated and converted to mammalian lignans enterolactone and enterodiol by gut microbiota, absorbed into blood, finally excreted in urine, bile and feces [9]. Lignans such as pinoresinol, lariciresinol, secoisolariciresinol diglucoside (SDG) and matairesinol which represented four different classes of lignans were converted to enterolignans through reduction, O-deglycosylation, O-demethylation, dehydrogenation and dihydroxylation by intestine bacteria [10]. However, only 55%, 62% and 72% of pinoresinol diglucoside, matairesinol and SDG were converted to enterolignans, respectively(11). A study showed that one hour after ingestion of sesame seeds, some lignans are quickly detected in the systemic circulation, such as pinoresinol, matairesinol, lariciresinol, secoisolariciresinol and sesamin, while other studies indicated that the enterolignans generally appeared in circulation 8–10 h after intake of dietary lignans [9]. Sacco et al. reported that after orally administering rats with trimer-labeled SDG for 7 days, 59.8% of the radioactivity, including the prototype and metabolites, was detected in the colon and cecum, while only 0.1% was detected in the entire skeletal tissue [12]. In addition, the fate of pure compounds does not invariably mirror the bioavailability of lignan within complex food or herbal medicines matrices. Therefore, the above publications suggest that the enterolignans or metabolites of lignans in the circulation might not be able to totally account for the beneficial actions of lignans on bone.

A Lignan-Rich Herb Sambucus willamsii Hance and its Effects on Bone

Sambucus williamsii Hance (SWH) belongs to Caprifoliaceae family and is widely distributed in China, Korea and Japan [13]. It is in the same genus as elderberry (also known as Sambucus nigra) which is popular in Europe to be used in products of syrup, gummies, soft drink, liqueur and eye gel. S. williamsii was first recorded in Tang Materia Medica (A.D. 659) for healing fractures and alleviating pain. Our previous studies have demonstrated that the SWH extract and its lignan-rich fraction increased BMD, improved trabecular bone micro-architecture, and promoted cortical bone strength in ovariectomized mouse and rat models [1417]. Fifty-six lignans were isolated and purified in the extract of SWH and were identified to be the bioactive components in SWH through the determination of the osteoblastic proliferation in vitro [18, 19].

A Question Arises from Pharmacokinetics Study

In order to identify the major bioavailable lignans that are associated with the bone protective effects of SWH, a pharmacokinetic study using rat model was carried out. The rats were administrated with an effective dose or a 15-times effective dose of the SWH fraction, followed by collection of the blood samples at 0, 5, 15, 30, 60, 120, 180, 240, 360, and 480 min. However, neither the prototype nor metabolites were detected by highly sensitive method using an ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS). To accumulate sufficient exogenous components in blood, samples were again collected and analyzed from rats gavaged daily with effective dose or 15-times effective dose of SWH fraction for 3 days. However, no detectable prototype nor metabolites of lignans could be detected in serum collected from these rats treated with SWH fraction for 3 days. The in-house results indicated that lignan-rich fraction may be composed of too many lignans with too low concentration of each type of lignan to be detected in blood. However, the lack of detectable lignans in the circulation might also suggest that mechanisms that do not require gastrointestinal uptake of lignans might be involved. This unsuccessful pharmacokinetic study prompted us to explore other mechanisms that might account for the bone protective effects of lignans.

Gut Microbiome Interaction with Lignan

Based on the fact that the bone protective effects of SWH was demonstrated in response to its oral administration, we hypothesized that lignans from SWH might exert its bone protective effect via the gut microbiome, including gut microbiota, their metabolites and their living environment [20]. An animal study using the lignan-rich fraction (CA) from SWH was performed to test the hypothesis [21]. Female SD rats (4-month old) were sham operated or ovariectomized, and treated with vehicle, PTH (1.8 µg/kg, n = 8, intramuscularly injected), CA (140 mg/kg, n = 10) for 10 weeks. The results exhibited that the lignan-rich fraction from SWH at 140 mg/kg prevented the reduction in BMD at distal femur and proximal tibia and improved bone microarchitecture in OVX rats, and these effects were similar to those of PTH on the trabecular bone.
The 16S rRNA sequencing of fecal samples showed that the microbial diversities of all groups increased significantly upon 10 weeks of treatment when compared to OVX group at 0 week, while no significant differences were found among the Sham, OVX and CA groups at week 10. The Principal Coordinate analysis (PCoA) and Partial least squares discriminant analysis (PLS-DA) analysis showed that the operational taxonomic units (OTUs) at week 10 were well separated from that at week 0, suggesting the microbial composition had altered over time. At week 10, the bacteria in the CA treatment group induced a significant separation from that of the Sham and OVX groups, indicating that CA treatment had significant influence on intestinal bacterial composition.
The difference analysis between groups and the LEfSe (linear discriminant analysis Effect Size) analysis showed that the abundance of Antinobacteria phylum extremely enriched in OVX rat fecal samples in response to CA treatment, and the taxa contributed to the abundance included: class, Antinobacteria; order, Coriobacteriales; family, Coriobacteriacene; genus, Adlercreutzia, norank_f_Coriobacteriaceae, Parvibacter, Enterorhabdus, Collinsella. The five genera belonged to Antinobacteria phylum were significantly reversed in the OVX rats treated with CA when compared with the OVX groups. These altered genera are related to the production of short chain fatty acid, modification of host bile acids and cholesterol levels, low dietary fiber intake and circulating insulin, cholesterol absorption, synthesis, and excretion [21]. Further spearman’s correlation analysis revealed that BMD was directly correlated with several genera, such as Lachnospiraceae_NK4A136_group and [Eubacterium] coprostanoligenes group, which are related to tryptophan metabolism. The results indicated that CA treatment might indirectly affect bone metabolism via modifying the metabolism of tryptophan in the gut.

Serotonin Involved in the Actions of Lignans on Bone

A metabolomic study was performed to identify if tryptophan metabolism was involved in the actions of lignans on bone. The resulted showed that tryptophan level in OVX rats was significantly restored upon treatment with the lignan-rich fraction of SWH for 12 weeks [17]. Tryptophan has two major catabolic pathways, the kynurenine (Kyn) pathway and serotonin (5-HT) pathway. The serum kynurenine level and serotonin level upon treatment with CA were quantified using an ultra-performance liquid chromatography tandem triple quadrupole mass spectrometry (UPLC-TQD-MS) method. The results showed that CA treatment significantly reduced serum 5-HT level, but not Kyn level, in OVX rats. The linear regression analysis showed that BMD was negatively correlated to serum 5-HT in rats [21].
Serotonin is best known as a neurotransmitter, and more than 90% of the body’s serotonin is synthesized by enterochromaffin cells in intestine, while the others is synthesized by clusters of neurons in brain. As serotonin cannot pass through the blood–brain barrier, all serotonin in the circulatory system comes from intestine. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme of 5-HT biosynthesis, and only the subtype of TPH-1 is located in the intestine, while the subtypes of TPH-1 and TPH-2 are distributed in the brain [22]. Our studies showed that CA significantly suppressed the protein expression of TPH-1 in the colon, while did not alter the protein expressions of TPH-1 and TPH-2 in cerebral cortex in OVX rats.
For the serotonin signaling pathway in osteoblast, the gut-derived 5-HT is delivered to osteoblasts by platelets, and its binding to the membrane 5HT1b receptor will then trigger the FOXO1/CRBE and FOXO1/ATF4 signaling cascade in osteoblastic cells. When high level of 5-HT acts on osteoblasts, the balance between FOXO1/CRBE and FOXO1/ATF4 will be broken and lead to the decrease in bone formation [23]. In our study, the mRNA and protein expressions of CREB in femur were not altered by OVX nor CA treatment. In contrast mRNA and protein expressions of ATF4 and FOXO1 in femur were significantly upregulated and downregulated in OVX rats, respectively; and these changes were significantly reversed in OVX rats in response to treatment with CA [21].
Taken together, our study clearly demonstrated that the lignan-rich fraction derived from Sambucus williamsii Hance exerted bone protective effects via altering circulating serotonin and gut microbiota.

Exploring a Novel Class of TPH-1 Inhibitor

Based on our discovery of the involvement of TPH-1 and serotonin in mediating the actions of lignan-rich fraction of SWH, subsequent study to identify TPH-1 inhibitors from SWH was performed [24]. The binding affinities of lignans isolated and purified from SWH were determined by molecular docking and surface plasmon resonance (SPR), the protein activity and expression of TPH-1 was tested in vitro, and serum serotonin level and BMD in mice upon treatment with purified lignan compound were measured. Our results showed that lignans derived from SWH exhibited high binding affinities to the TPH-1 protein, inhibited the activity and expression of TPH-1 in RBL2H3 cells, the Tph-1 gene high-expressing cells, and suppressed serum serotonin levels as well as significantly improved BMD in OVX mice. A series of novel class TPH-1 inhibitors, the lignans derived from SWH, were explored. The results provided the direct evidence that lignans could act on TPH-1 and influence serotonin synthesis and its circulating levels, thereby indirectly modulate bone metabolism in OVX animal model.

Conclusion

The mechanism of actions of lignan derived from SWH were summarized in Fig. 1. In conclusion, lignans appear to exert protective effects on bone by modulating the composition of microbiota and suppressing the synthesis of gut-derived serotonin, without the need to be absorbed into the circulation. Microbiome, including microbiota, their metabolites and their living environment, is an indispensable factor for lignans to exert bone beneficial effects.
Fig. 1
The action scheme of lignan-rich fraction derived from Sambucus williamsii Hance one bone
Bild vergrößern

Key References

  • International Osteoporosis Foundation. Epidemiology of osteoporosis and fragility fractures. https://www.osteoporosis.foundation/facts-statistics/epidemiology-of-osteoporosis-and-fragility-fractures: International Osteoporosis Foundation. 2024.
    • Overview the latest epidemiology of osteoporosis and fragility fractures worldwide, along with the burden and impact of hip fractures and vertebral fractures, and outlined the rate of fractures caused by falls and the risk of secondary fractures.
  • Batool I, Altemimi AB, Munir S, Imran S, Khalid N, Khan MA, et al. Exploring flaxseed's potential in enhancing bone health: Unveiling osteo-protective properties. Journal of agriculture and food research 2024; 15: 101,018.
    • Comprehensive overview of the bone protective efficacy of flaxseed in different forms like oil, flour, extract and powder in preclinical experiments and clinical trials, and revealed the mechanism of promoting bone health and density by unsaturated fatty acid, lignans and fiber in flaxseeds.
  • Arooj A, Rabail R, Naeem M, Goksen G, Xu B, Aadil RM. A comprehensive review of the bioactive components of sesame seeds and their impact on bone health issues in postmenopausal women. Food Funct 2023;14(11):4966–498.
    • Good summary of the positive role of sesame seeds on bone health in postmenopausal women and animal models, and the nutritional composition and bioactive ingredients of sesame seeds. Supported the use of sesame seeds as supplements in regular diet.

Declarations

Competing Interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
download
DOWNLOAD
print
DRUCKEN
Titel
Lignans from Sambucus williamsii Protect Bone Via Microbiome
Verfasst von
Hui-Hui Xiao
Daniel Kam-Wah Mok
Xin-Sheng Yao
Man-Sau Wong
Publikationsdatum
05.09.2024
Verlag
Springer US
Erschienen in
Current Osteoporosis Reports / Ausgabe 6/2024
Print ISSN: 1544-1873
Elektronische ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-024-00883-1
1.
Zurück zum Zitat World Health Organization. Aging and health. 2022. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health: World Health Organization. Accessed 24 Apr 2024.
2.
Zurück zum Zitat International Osteoporosis Foundation. Epidemiology of osteoporosis and fragility fractures. 2024. https://www.osteoporosis.foundation/facts-statistics/epidemiology-of-osteoporosis-and-fragility-fractures: International Osteoporosis Foundation. Accessed 24 Apr 2024.
3.
Zurück zum Zitat Domínguez-López I, Yago-Aragón M, Salas-Huetos A, Tresserra-Rimbau A, Hurtado-Barroso S. Effects of dietary phytoestrogens on hormones throughout a human lifespan: a review. Nutrients. 2020;12(8):2456.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P, Gallelli L. Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA modulation. Molecules. 2019;25(1):63.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Rodríguez-García C, Sánchez-Quesada C, Toledo E, Delgado-Rodríguez M, Gaforio JJ. Naturally lignan-rich foods: a dietary tool for health promotion? Molecules. 2019;24(5):917.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Batool I, Altemimi AB, Munir S, Imran S, Khalid N, Khan MA, et al. Exploring flaxseed’s potential in enhancing bone health: unveiling osteo-protective properties. J Agric Food Res. 2024;15:101018.
7.
Zurück zum Zitat Arooj A, Rabail R, Naeem M, Goksen G, Xu B, Aadil RM. A comprehensive review of the bioactive components of sesame seeds and their impact on bone health issues in postmenopausal women. Food Funct. 2023;14(11):4966–5498.CrossRefPubMed
8.
Zurück zum Zitat Dodin S, Lemay A, Jacques H, Légaré F, Forest JC, Mâsse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab. 2005;90(3):1390–7.
9.
Zurück zum Zitat Soleymani S, Habtemariam S, Rahimi R, Nabavi SM. The what and who of dietary lignans in human health: Special focus on prooxidant and antioxidant effects. Trends Food Sci Technol. 2020;106:382–90.CrossRef
10.
Zurück zum Zitat Clavel T, Doré J, Blaut M. Bioavailability of lignans in human subjects. Nutr Res Rev. 2006;19(2):187–96.CrossRefPubMed
11.
Zurück zum Zitat Peterson J, Dwyer J, Adlercreutz H, Scalbert A, Jacques P, McCullough ML. Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev. 2010;68(10):571–603.CrossRefPubMed
12.
Zurück zum Zitat Sacco SM, Thompson LU, Ganss B, Ward WE. Accessibility of 3H-Secoisolariciresinol diglycoside Lignan metabolites in skeletal tissue of ovariectomized rats. J Med Food. 2011;14(10):1208–14.CrossRefPubMed
13.
Zurück zum Zitat Lei X, Zhang Y, Wei X, Tang Y, Qu Q, Zhao X, et al. Sambucus williamsii Hance: a comprehensive review of traditional uses, processing specifications, botany, phytochemistry, pharmacology, toxicology, and pharmacokinetics. J Ethnopharmacol. 2024;326:117940.CrossRefPubMed
14.
Zurück zum Zitat Xie F, Wu CF, Zhang Y, Yao XS, Cheung PY, Chan AS, et al. Increase in bone mass and bone strength by Sambucus williamsii HANCE. Biol Pharm Bull. 2005;28(10):1879–85.CrossRefPubMed
15.
Zurück zum Zitat Zhang Y, Li Q, Wan HY, Xiao HH, Lai WP, Yao XS, et al. Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects aginst ovariectomy-induced osteoporosis in vivo. Osteoporos Int. 2011;22(2):703–9.CrossRefPubMed
16.
Zurück zum Zitat Xiao HH, Dai Y, Wan HY, Wong MS, Yao XS. Bone protective effects of bioactive fractions and ingredients in Sambucus williamsii HANCE. Br J Nutr. 2011;106(12):1802–9.CrossRefPubMed
17.
Zurück zum Zitat Xiao HH, Sham TT, Chan CO, Li MH, Chen X, Wu QC, et al. A metabolomics study on the bone protective effects of a lignan-rich fraction from Sambucus Williamsii Ramulus in aged rats. Front Pharmacol. 2018;9:932.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Xiao HH, Dai Y, Wong MS, Yao XS. New lignans from the bioactive fraction of Sambucus williamsii Hance and proliferation activities on osteoblastic-like UMR106 cells. Fitoterapia. 2014;94C:29–35.CrossRef
19.
Zurück zum Zitat Xiao HH, Lv J, Mok D, Yao XS, Wong MS, Cooper R. NMR applications for botanical mixtures: the use of HSQC data to determine lignan content in Sambucus williamsii. J Nat Prod. 2019;82(7):1733–40.CrossRefPubMed
20.
Zurück zum Zitat Berg G, Rybakova D, Fischer D, Cernava T, Vergès MC, Charles T, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Xiao HH, Zhu YX, Lu L, Zhou LP, Poon CCW, Chan CO, et al. The lignan-rich fraction from Sambucus williamsii Hance exerts bone protective effects via altering circulating serotonin and gut microbiota in rats. Nutrients. 2022;14:4718.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;163(1):258.CrossRef
23.
Zurück zum Zitat Lavoie B, Lian JB, Mawe GM. Regulation of bone metabolism by serotonin. Adv Exp Med Biol. 2017;1033:35–46.CrossRefPubMed
24.
Zurück zum Zitat Zhu YX, Tang ZL, Lu L, Qiu ZC, Pan DB, Yu Y, et al. Exploring a novel class tryptophan hydroxylase 1 inhibitor derived from Sambucus williamsii Hance for the osteoporosis treatment. Acupunct Herbal Med. 2024;4(1):102–12.CrossRef

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie erweitert durch Fallbeispiele, Videos und Abbildungen. Zur Fortbildung und Wissenserweiterung, verfasst und geprüft von Expertinnen und Experten der Gesellschaft für Arthroskopie und Gelenkchirurgie (AGA).


Jetzt entdecken!

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Mit Glukokortikoiden überbrücken? Studie stützt europäische Rheuma-Leitlinie

Glukokortikoide, die zu Beginn einer krankheitsmodifizierenden Rheumatherapie begleitend eingesetzt werden, lassen sich in den allermeisten Fällen planmäßig ausschleichen und absetzen: Das Ergebnis der ARCTIC-Studie spricht diesbezüglich für die europäische und gegen die US-amerikanische Leitlinie.

7% durch chronische Schmerzen stark beeinträchtigt

Laut einer Querschnittstudie leiden rund 7% der in Deutschland lebenden über 16-Jährigen unter chronischen Schmerzen, die ihren Alltag stark beeinträchtigen. Außer biologischen scheinen auch psychische und soziale Faktoren mit sogenanntem High-Impact Chronic Pain assoziiert zu sein.

Elektroschrott: Wie Praxen Altgeräte sicher entsorgen

Ob nun Sonogerät, Praxiscomputer oder gar TI-Konnektor: Einfach zum nächsten Wertstoffhof sollten Praxisteams ausgediente Elektrogeräte nicht bringen. Was bei der Entsorgung zu beachten ist. Und wie die Teams sicher sensible Daten auf PC-Festplatte, externem Datenspeicher und TI-Komponenten löschen.

Tipps: So können Praxen die Risiken für einen GOÄ-Streit minimieren

Für Streitigkeiten, die das GOÄ-Honorar betreffen, sind neuerdings nur noch Landgerichte zuständig. Das macht Prozesse teurer. Eine Praxisberaterin erläutert, wie Praxen vorbauen können, um solche Streitfälle und Gerichtsverfahren zu vermeiden.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Arthropedia, Verschiedene Tabletten/© zozzzzo / Getty Images / iStock, Ultraschalluntersuchung der Niere/© Your_Photo_Today (Symbolbild mit Fotomodellen), Richter mit Gesetzbuch/© Kzenon / stock.adobe.com (Symbolbild mit Fotomodell)